Stay updated on Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page revision label changed from v3.5.4 to v3.5.5, indicating a minor version update to the document.
    Difference
    0.0%
    Check dated 2026-06-09T16:44:32.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.5.3 to v3.5.4, indicating an update to the site's frontend template used for displaying the study details. There are no visible changes to study information or page layout described by the provided data.
    Difference
    0.0%
    Check dated 2026-05-19T10:25:47.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new revision tag v3.5.3 was added and the previous v3.5.0 tag was removed, indicating an administrative update to the study record's revision history. This update does not affect study data, eligibility criteria, or user-facing content.
    Difference
    0.0%
    Check dated 2026-04-27T19:32:47.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    Napoli, Italy, 80131 was updated to Naples, Italy, 80131. The page revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T22:09:36.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    The website revision was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T12:32:36.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Layout/UI updates were observed on the Study Details page. Core study information such as eligibility criteria, outcomes, and locations remains unchanged.
    Difference
    0.0%
    Check dated 2026-02-28T05:59:29.000Z thumbnail image

Stay in the know with updates to Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page.